Hyperactivation of the JAK2/STAT5 Signaling Pathway and Evaluation of Baricitinib Treatment Among Patients With Eosinophilic Cellulitis.
Morot J, Del Duca E, Chastagner M, Fernandes M, Estrada Y, Lefevre MA, Kanitakis J, Harou O, Jullien D, Nicolas JF, Krueger JG, Vocanson M, Guttman-Yassky E, Villani AP.
Morot J, et al. Among authors: kanitakis j.
JAMA Dermatol. 2023 Aug 1;159(8):820-829. doi: 10.1001/jamadermatol.2023.1651.
JAMA Dermatol. 2023.
PMID: 37342057